Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Scott

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|April 1, 2011
Provider experiences with RAC appeals point to opportunities for program improvementRobert Jacobs, Bonnie Scott, Elizabeth Flood, et al.
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|September 20, 2011
The forecast for RAC extrapolation: mostly cloudyElizabeth Goldman, Robert Jacobs, Ellen Scott, et al.
Plos One|April 7, 2016
Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell TherapyKrithika N Kodumudi, Jessica Siegel, Amy M Weber, et al.
Plos One|April 26, 2018
T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma modelHao Liu, Amy Weber, Jennifer Morse, et al.
Journal of Mass Spectrometry : JMS|July 12, 2002
Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humansBlandine Comte, Takhar Kasumov, Bradley A Pierce, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2020
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma modelBrittany L Bunch, Krithika N Kodumudi, Ellen Scott, et al.
BMJ Open|October 3, 2019
The NoHoW protocol: a multicentre 2×2 factorial randomised controlled trial investigating an evidence-based digital toolkit for weight loss maintenance in European adultsSarah Ellen Scott, Cristiana Duarte, Jorge Encantado, et al.
Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|April 1, 2011
Provider experiences with RAC appeals point to opportunities for program improvementRobert Jacobs, Bonnie Scott, Elizabeth Flood, et al.
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|September 20, 2011
The forecast for RAC extrapolation: mostly cloudyElizabeth Goldman, Robert Jacobs, Ellen Scott, et al.
Plos One|April 7, 2016
Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell TherapyKrithika N Kodumudi, Jessica Siegel, Amy M Weber, et al.
Plos One|April 26, 2018
T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma modelHao Liu, Amy Weber, Jennifer Morse, et al.
Journal of Mass Spectrometry : JMS|July 12, 2002
Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humansBlandine Comte, Takhar Kasumov, Bradley A Pierce, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2020
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma modelBrittany L Bunch, Krithika N Kodumudi, Ellen Scott, et al.
BMJ Open|October 3, 2019
The NoHoW protocol: a multicentre 2×2 factorial randomised controlled trial investigating an evidence-based digital toolkit for weight loss maintenance in European adultsSarah Ellen Scott, Cristiana Duarte, Jorge Encantado, et al.
Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Pageof 1